BREAKING
Synergy CHC Corp. (SNYR) Q4 Earnings: Misses on EPS, Revenue Recap 18 hours ago Lindsay Corporation Q2: Revenue Slips to $157.7M 18 hours ago Kaiser Aluminum Corporation (KALU) Jumps 7.1% to $129.05 19 hours ago Sterling Infrastructure, Inc. (STRL) Jumps 5.9% to $431.23 19 hours ago Penguin Solutions Q2 Fiscal 2026 Financial Review 20 hours ago Talos Energy Inc. (TALO) Jumps 5.6% to $15.77 21 hours ago AirSculpt Technologies, Inc. (AIRS) Q4 Earnings: Beats on EPS, Revenue Recap 21 hours ago Acuity Inc. (AYI) Q2 2026 Earnings Recap 21 hours ago Hasbro, Inc. (HAS) Drops 5.0% to $88.89 22 hours ago Lindsay Corporation (LNN) Reports Q2 Earnings 22 hours ago Synergy CHC Corp. (SNYR) Q4 Earnings: Misses on EPS, Revenue Recap 18 hours ago Lindsay Corporation Q2: Revenue Slips to $157.7M 18 hours ago Kaiser Aluminum Corporation (KALU) Jumps 7.1% to $129.05 19 hours ago Sterling Infrastructure, Inc. (STRL) Jumps 5.9% to $431.23 19 hours ago Penguin Solutions Q2 Fiscal 2026 Financial Review 20 hours ago Talos Energy Inc. (TALO) Jumps 5.6% to $15.77 21 hours ago AirSculpt Technologies, Inc. (AIRS) Q4 Earnings: Beats on EPS, Revenue Recap 21 hours ago Acuity Inc. (AYI) Q2 2026 Earnings Recap 21 hours ago Hasbro, Inc. (HAS) Drops 5.0% to $88.89 22 hours ago Lindsay Corporation (LNN) Reports Q2 Earnings 22 hours ago
ADVERTISEMENT
REGN

Regeneron Pharmaceuticals Inc

$REGN NASDAQ Apr 2, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

REGN Coverage

Event Regeneron Pharmaceuticals Inc (REGN) TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions Apr 2, 2026 Event Regeneron Pharmaceuticals Inc (REGN) EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Apr 2, 2026 Event Regeneron Pharmaceuticals Inc (REGN) Q1 2026 Earnings Call Mar 25, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript Feb 2, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% May 4, 2023 Press Release Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31% Feb 3, 2023